[1] Alexander LF, Patel NJ, Caserta MP, et al.Thyroid Ultrasound: Diffuse and Nodular Disease[J]. Radiol Clin North Am, 2020, 58(6):1041-1057. [2] Awad SAS, Ashraf EM, Khaled AS, et al.The epidemiology of thyroid diseases in the Arab world: A systematic review[J]. J Public Health Epidemiol, 2016, 8(2):17-26. [3] 李咏泽, 滕卫平, 单忠艳. 2015—2017年中国不同碘摄入地区甲状腺疾病患病率及相关因素调查[J]. 中华医学杂志,2023,103(5):350-355. [4] Alexander LF, Patel NJ, Caserta MP, et al.Thyroid Ultrasound: Diffuse and nodular disease[J]. Radiol Clin North Am, 2020, 58(6):1041-1057. [5] Liu F, Zhang X.Hypertension and obesity: Risk factors for thyroid disease[J]. Front Endocrinol (Lausanne), 2022, 13:939367. [6] Li Y, Teng D, Ba J, et al.Efficacy and safety of long-term universal salt iodization on thyroid disorders: epidemiological evidence from 31 provinces of mainland China[J]. Thyroid, 2020, 30(4): 568-579. [7] World Health Organization.Guidelines for controlling and monitoring the tobacco epidemic[M]. Geneva: World Health Organization, 1998:76-77. [8] World Health Organization.Global status report on alcohol and health 2014[M]. Geneva: World Health Organization, 2014:4. [9] 左媛媛, 郭宏宇, 郭文秀,等. 呼和浩特市体检人群甲状腺疾病患病情况及其危险因素研究[J]. 中华地方病学杂志, 2020, 39(7): 477-482. [10] 《中国高血压基层管理指南》修订委员会. 中国高血压基层管理指南(2014年修订版)[J]. 中华高血压杂志, 2015, 23(1) : 24-43. [11] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中国实用内科杂志, 2018, 38(4):292-344. [12] 中国成人血脂异常防治指南修订联合委员会. 中国成人血脂异常防治指南(2016年修订版)[J]. 中华全科医师杂志, 2017, 16(1):15-35. [13] 申红梅. 个体碘营养评价方法现状及展望[J].中华地方病学杂志, 2017, 36(3): 162-165. [14] 高明. 甲状腺结节和分化型甲状腺癌诊治指南[J]. 中国肿瘤临床, 2012(17): 1249-1272. [15] 中华医学会内分泌学分会《中国甲状腺疾病诊治指南》编写组. 中国甲状腺疾病诊治指南[M]. 北京: 中华内分泌学分会, 2007: 1-4. [16] Li YZ, Teng D, Ba JM, et al.Efficacy and safety of long-term universal salt iodization on thyroid disorders: An epidemiological evidence from 31 provinces of Mainland China[J]. Thyroid, 2020, 30(4): 568-579. [17] 王健辉,孙蕾,冯晓伟,等. 辽宁省成人甲状腺疾病流行状况及影响因素[J]. 中国公共卫生, 2022, 38(9):1187-1192. [18] Taylor PN, Albrecht D, Scholz A, et al.Global epidemiology of hyperthyroidism and hypothyroidism[J]. Nat Rev Endocrinol. 2018, 14(5):301-316. [19] Kim YA, Park YJ.Prevalence and risk factors of subclinical thyroid disease[J]. Endocrinol Metab (Seoul), 2014, 29(1):20-29. [20] Akhtar MA, Agrawal R, Brown J, et al. Thyroxine replacement for subfertile women with euthyroid autoimmune thyroid disease or subclinical hypothyroidism[J]. Cochrane Database Syst Rev, 2019, 6(6):CD011009. [21] 黄慧, 马瑞婷, 闫哲. 雌激素在桥本氏甲状腺炎中的作用[J]. 西部医学, 2015, 27(10): 1441-1444 [22] 吴南燕, 王建刚, 董苗. 妊娠合并亚临床甲状腺功能减退症的相关因素分析[J]. 现代诊断与治疗, 2019, 30(21):132-134. [23] 刘婷婷, 滕卫平. 中国国民碘营养现状与甲状腺疾病[J].中华内科杂志, 2017, 56(1):62-64. [24] 宋博, 滕卫平. 碘对甲状腺结节的影响研究进展[J]. 中国地方病防治杂志, 2020, 35(4):426-428. [25] 李康. 碘营养状况与结节性甲状腺肿及甲状腺乳头状癌相关关系研究 [D]. 北京: 北京协和医学院, 2017: 1-32. [26] Flores-Rebollar A, Moreno-Castañeda L, Vega-Servín NS, et al. Prevalence of autoimmune thyroiditis and thyroid dysfunction in healthy adult Mexicans with a slightly excessive iodine intake[J]. Nutr Hosp,2015, 32(2): 923-929. [27] Bílek R, Dvořáková M, Grimmichová T, et al.Iodine, thyroglobulin and thyroid gland[J]. Physiol Res,2020, 69(Suppl 2):S225-S236. [28] Farebrother J, Zimmermann MB, Andersson M.Excess iodine intake:Sources, assessment, and effects on thyroid function[J]. Ann N Y Acad Sci, 2019, 1446(1):44-65. |